Massachusetts General Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02114.
Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.
Massachusetts General Cancer Center has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Cutaneous Squamous Cell Carcinoma, Antibody-mediated Rejection.
Sponsors: Regeneron Pharmaceuticals, CSL Behring.
Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Massachusetts General Cancer Center has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Massachusetts General Cancer Center has 2 clinical trials on record, with 1 currently active. Their work covers Cutaneous Squamous Cell Carcinoma, Antibody-mediated Rejection.
Massachusetts General Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.